Zhuhai Jianfu Pharmaceutical Co., Ltd. announced that it expects to receive CNY 15 million in funding from Jafron Biomedical Co.,Ltd.
October 22, 2023
Share
Zhuhai Jianfu Pharmaceutical Co., Ltd. announced that it will receive CNY 15 million equity round of funding on October 23, 2023. The transaction included the participation from new investor Jafron Biomedical Co.,Ltd., hold 10% stake. Upon completion, the registered capital of a company will increase from CNY 100 million to CNY 250 million.
The company held that the transaction has been approved by the 10th meeting of the 5th Board of Directors and the 8th meeting of the 5th Board of Supervisors.
Jafron Biomedical Co.,Ltd. is a China-based company principally engaged in the research, design, manufacture and distribute of biological materials and medical equipment. The Companyâs products include disposable hemoperfusion devices, hemoperfusion machine, disposable bilirubin adsorbers, DX-10 blood purification machine, suture needle, as well as resins bandage, among others. The Companyâs products are applied in uremia, poisoning, severe liver diseases, autoimmune diseases, as well as multisystem organ failure, among others. The Companyâs products are applied in 31 provinces, more than 3000 hospitals in China.
JAFRON BIOMEDICAL CO.,LTD. 
